{"title":"SARS-CoV-2与流感病毒的共循环、共感染,将何去何从?","authors":"Shuai Wang, Dayan Wang","doi":"10.15212/zoonoses-2023-0006","DOIUrl":null,"url":null,"abstract":"COVID-19 has led to unprecedented public health challenges and may become a long-term problem for humans. Influenza, an important infectious disease that causes seasonal influenza, and can potentially reach pandemic status, has led to concerns regarding co-circulation with COVID-19. On the basis of surveillance data for COVID-19 and influenza reported to the WHO in the past 3 years, both infections did not peak together. The co-infection rate (0.7%) for COVID-19 and influenza was relatively low. However, the co-infection rate was significantly higher among people with relatively low immunity and severe symptoms, and co-infection might increase the proportion of severe illness and mortality. Awareness of co-infection is important, and timely evaluation of the risk of co-circulation and co-infection of SARS-CoV-2 and influenza virus will be critical in upcoming influenza seasons. Measures should be taken to prevent co-infection with SARS-CoV-2 and influenza virus, including maximizing uptake of the influenza vaccination and early use of anti-influenza drugs, particularly in groups at high risk of both diseases. Furthermore, prevention and control strategies should include not only SARS-CoV-2 and influenza virus, but also other respiratory diseases, to better prevent the co-occurrence of multiple diseases.","PeriodicalId":79199,"journal":{"name":"Zoonoses research","volume":"226 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Co-circulation, Co-infection of SARS-CoV-2 and Influenza Virus, Where Will it Go?\",\"authors\":\"Shuai Wang, Dayan Wang\",\"doi\":\"10.15212/zoonoses-2023-0006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"COVID-19 has led to unprecedented public health challenges and may become a long-term problem for humans. Influenza, an important infectious disease that causes seasonal influenza, and can potentially reach pandemic status, has led to concerns regarding co-circulation with COVID-19. On the basis of surveillance data for COVID-19 and influenza reported to the WHO in the past 3 years, both infections did not peak together. The co-infection rate (0.7%) for COVID-19 and influenza was relatively low. However, the co-infection rate was significantly higher among people with relatively low immunity and severe symptoms, and co-infection might increase the proportion of severe illness and mortality. Awareness of co-infection is important, and timely evaluation of the risk of co-circulation and co-infection of SARS-CoV-2 and influenza virus will be critical in upcoming influenza seasons. Measures should be taken to prevent co-infection with SARS-CoV-2 and influenza virus, including maximizing uptake of the influenza vaccination and early use of anti-influenza drugs, particularly in groups at high risk of both diseases. Furthermore, prevention and control strategies should include not only SARS-CoV-2 and influenza virus, but also other respiratory diseases, to better prevent the co-occurrence of multiple diseases.\",\"PeriodicalId\":79199,\"journal\":{\"name\":\"Zoonoses research\",\"volume\":\"226 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zoonoses research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15212/zoonoses-2023-0006\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zoonoses research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15212/zoonoses-2023-0006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Co-circulation, Co-infection of SARS-CoV-2 and Influenza Virus, Where Will it Go?
COVID-19 has led to unprecedented public health challenges and may become a long-term problem for humans. Influenza, an important infectious disease that causes seasonal influenza, and can potentially reach pandemic status, has led to concerns regarding co-circulation with COVID-19. On the basis of surveillance data for COVID-19 and influenza reported to the WHO in the past 3 years, both infections did not peak together. The co-infection rate (0.7%) for COVID-19 and influenza was relatively low. However, the co-infection rate was significantly higher among people with relatively low immunity and severe symptoms, and co-infection might increase the proportion of severe illness and mortality. Awareness of co-infection is important, and timely evaluation of the risk of co-circulation and co-infection of SARS-CoV-2 and influenza virus will be critical in upcoming influenza seasons. Measures should be taken to prevent co-infection with SARS-CoV-2 and influenza virus, including maximizing uptake of the influenza vaccination and early use of anti-influenza drugs, particularly in groups at high risk of both diseases. Furthermore, prevention and control strategies should include not only SARS-CoV-2 and influenza virus, but also other respiratory diseases, to better prevent the co-occurrence of multiple diseases.